BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Western Australian Health Translation Network - ECPv6.3.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Western Australian Health Translation Network
X-ORIGINAL-URL:https://wahtn.org
X-WR-CALDESC:Events for Western Australian Health Translation Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Shanghai
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:CST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20181011T093000
DTEND;TZID=Asia/Shanghai:20181011T140000
DTSTAMP:20260825T052707
CREATED:20180911T031843Z
LAST-MODIFIED:20180911T032212Z
UID:3882-1539250200-1539266400@wahtn.org
SUMMARY:Pitching to Investors Masterclass
DESCRIPTION:AusBiotech is pleased to deliver the ‘Pitching to Investors Masterclass’ session in Perth. We have developed a masterclass aimed at assisting leaders of life sciences companies successfully pitch to investors. The masterclass\, in partnership with the Australian Securities Exchange (ASX)\, KPMG\, Dentons (formerly DibbsBarker) and WE Buchan\, is one of the three main components of the MTPConnect-funded ‘Comprehensive Global Investment Program for the Australian Life Sciences Sector’ project. The session will be facilitated by secondnature\, a training consultancy that specialises in helping business professionals transform their communication and presentation abilities. \nAs well as founder CEOs of life sciences companies\, the masterclass will be aimed at life sciences companies and researchers looking to commercialise their research. The masterclass will provide tools to prepare and develop a relevant and effective narrative for their company and product as well as improved pitching skills. All participants will be required to prepare and present a 7-minute company/product pitch during the Masterclass. Pre-workshop notes will be provided to all participants to assist with preparation for this (see below for more information). \nThe session is limited to 10 participants. \nA subsidised rate of $150 for AusBiotech members and $250 for non-members is made possible by MTPConnect Project Funding. \nIf you are interested\, click here to  submit your EOI by 20 September 2018. \nEnquiries should be directed to Dr Claretta DSouza\, National Projects Manager\, AusBiotech\n\n\n\n\n\n\n\n 
URL:https://wahtn.org/event/pitching-to-investors-masterclass/
LOCATION:KPMG Perth\, 235 St Georges Terrace
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Shanghai:20181011T120000
DTEND;TZID=Asia/Shanghai:20181011T130000
DTSTAMP:20260825T052707
CREATED:20181009T073141Z
LAST-MODIFIED:20181009T074824Z
UID:3960-1539259200-1539262800@wahtn.org
SUMMARY:Perkins Seminar series: "Engineering the placenta: Advances in understanding fetal growth restriction" and "Understanding the complex flow patterns of the diseased aorta: A basis for risk quantification and pre-surgical planning"
DESCRIPTION:Title: “Engineering the placenta: Advances in understanding fetal growth restriction” \nPresenter: Nikhilesh Bappoo \nPhD Student\, Vascular Engineering Laboratory \nHarry Perkins Institute of Medical Research \n  \nTitle: “Understanding the complex flow patterns of the diseased aorta: A basis for risk quantification and pre-surgical planning” \nPresenter: Louis Parker \nPhD Student\, Vascular Engineering Laboratory Harry Perkins Institute of Medical Research \n  \nPlease see attached flyer
URL:https://wahtn.org/event/perkins-seminar-series/
LOCATION:Harry Perkins Institute of Medical Research NORTH\, 6 Verdun St\, Nedlands\, Perth\, Western Australia\, 6009\, Australia
END:VEVENT
END:VCALENDAR